Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 73 INDUSTRY 33 NIH 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Sarcoma 3 Breast 3 Thoracic 2 Gynecologic 2 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 Endocrine 1

Conditions

Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Radiotherapy 34 Gemcitabine 24 Docetaxel 24 bicalutamide 23 Goserelin 21 Paclitaxel 19 Cisplatin 19 Doxorubicin 18 Carboplatin 18 Flutamide 17 Leuprolide 16 Radiotherapy, Conformal 13 Etoposide 13 Filgrastim 12 Prednisone 11 Gene Expression Profiling 11 Gonadotropin-Releasing Hormone 10 Radiotherapy, Intensity-Modulated 9 Vincristine 8 Vinblastine 8 Triptorelin Pamoate 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Buserelin 8 Androgen Antagonists 8 Surgical Procedures, Operative 7 Radiation 7 Polymerase Chain Reaction 7 Methotrexate 7 Estramustine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Everolimus × Genitourinary × Clear all

NCT01120249 2025-09-16

S0931

SWOG Cancer Research Network

Phase 3 Completed

1,545 enrolled 15 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡